Korean J Hematol.  2002 Nov;37(4):287-291.

Atypical Hairy Cell Leukemia

Affiliations
  • 1Department of Internal Medicine, Soon Chun Hyang University College of Medicine, Seoul, Korea. dshong@schbc.ac.kr
  • 2Department of Laboratory Medicine, Soon Chun Hyang University College of Medicine, Seoul, Korea.
  • 3Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea.

Abstract

We experienced a case of atypical hairy cell leukemia in a 42-year-old woman. She showed marked splenomegaly without palpable lymphadenopathy. Complete blood cell count revealed leukocytosis at 44,000/micro L with lymphocytes 74% and peripheral blood smear showed abnormal lymphoid cells with cytoplasmic projections. The bone marrow was easily aspirated and also revealed the abnormal lymphocytes in up to 95%. Tartrate-resistant acid phosphatase reactivity was negative in the hairy cells. Immunophenotyping results of lymphoid cells were CD5(-), CD7(-), CD10(-), CD19(+), and HLA-DR(+). She was treated with an adenosine analogue, fludarabine at a daily dose of 30mg/m2 for 5 consecutive days, every four weeks. Immediately after treatment, the size of the spleen was normalized. Correct diagnosis was difficult due to insufficient laboratory and pathologic data. The differential diagnosis of mature B-cell neoplasms with cytoplasmic projections in patients with splenomegaly includes hairy cell leukemia and splenic lymphoma with villous lymphocytes. We herein described the present case with a brief review of the literature.

Keyword

Differential diagnosis; Hairy cell leukemia; Splenic lymphoma with villous lymphocytes

MeSH Terms

Acid Phosphatase
Adenosine
Adult
B-Lymphocytes
Blood Cell Count
Bone Marrow
Cytoplasm
Diagnosis
Diagnosis, Differential
Female
Humans
Immunophenotyping
Leukemia, Hairy Cell*
Leukocytosis
Lymphatic Diseases
Lymphocytes
Lymphoma
Spleen
Splenomegaly
Acid Phosphatase
Adenosine
Full Text Links
  • KJH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr